GB2437054B - A process for the preparation of an orally administered unit dose tablet - Google Patents

A process for the preparation of an orally administered unit dose tablet

Info

Publication number
GB2437054B
GB2437054B GB0607276A GB0607276A GB2437054B GB 2437054 B GB2437054 B GB 2437054B GB 0607276 A GB0607276 A GB 0607276A GB 0607276 A GB0607276 A GB 0607276A GB 2437054 B GB2437054 B GB 2437054B
Authority
GB
United Kingdom
Prior art keywords
preparation
unit dose
orally administered
dose tablet
administered unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0607276A
Other versions
GB0607276D0 (en
GB2437054A (en
Inventor
Michael Hilary Burke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0607276A priority Critical patent/GB2437054B/en
Publication of GB0607276D0 publication Critical patent/GB0607276D0/en
Publication of GB2437054A publication Critical patent/GB2437054A/en
Application granted granted Critical
Publication of GB2437054B publication Critical patent/GB2437054B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
GB0607276A 2006-04-11 2006-04-11 A process for the preparation of an orally administered unit dose tablet Expired - Fee Related GB2437054B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0607276A GB2437054B (en) 2006-04-11 2006-04-11 A process for the preparation of an orally administered unit dose tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0607276A GB2437054B (en) 2006-04-11 2006-04-11 A process for the preparation of an orally administered unit dose tablet

Publications (3)

Publication Number Publication Date
GB0607276D0 GB0607276D0 (en) 2006-05-17
GB2437054A GB2437054A (en) 2007-10-17
GB2437054B true GB2437054B (en) 2010-09-22

Family

ID=36539746

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0607276A Expired - Fee Related GB2437054B (en) 2006-04-11 2006-04-11 A process for the preparation of an orally administered unit dose tablet

Country Status (1)

Country Link
GB (1) GB2437054B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591456A (en) * 1995-02-10 1997-01-07 Nanosystems L.L.C. Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
WO2003066030A2 (en) * 2002-02-07 2003-08-14 Pharmacia Corporation Pharmaceutical tablet
WO2004014346A1 (en) * 2002-08-06 2004-02-19 Pfizer Products Inc. Palatable controlled-release formulation for companion animals
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591456A (en) * 1995-02-10 1997-01-07 Nanosystems L.L.C. Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
WO2003066030A2 (en) * 2002-02-07 2003-08-14 Pharmacia Corporation Pharmaceutical tablet
WO2004014346A1 (en) * 2002-08-06 2004-02-19 Pfizer Products Inc. Palatable controlled-release formulation for companion animals
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen

Also Published As

Publication number Publication date
GB0607276D0 (en) 2006-05-17
GB2437054A (en) 2007-10-17

Similar Documents

Publication Publication Date Title
IL206159A0 (en) Oral pharmaceutical dosage forms
SI2343071T1 (en) Pharmaceutical dosage forms
IL226702A (en) Therapeutic isoxazole compounds for the preparation of medicaments
IL193727A0 (en) Dosage forms for administering combinations of drugs
GB2448224B (en) Solid orally administered pharmaceutical composition for the reduction of side-effects of a dopaminergic agent
RS55705B1 (en) Pharmaceutical dosage form containing pharmaceutically acceptable solubilizing composition
GB0703507D0 (en) Solid pharmaceutical dose
IL197316A0 (en) Buprenophine-wafer for drug substitution therapy
IL199472A0 (en) Non-effervescent, orally disintegrating solid pharmaceutical dosage forms, processes for the preparation of the same and uses thereof
GB2455875B (en) A process for the preparation of an orally administered unit dose tablet
EP2112925A4 (en) Solid pharmaceutical dosage formulations
HK1134902A1 (en) Compounds a-r-x for the manufacture of pharmaceutical preparations
EP2206519A4 (en) Medicinal preparation for oral administration
GB0703674D0 (en) A Process For The Preparation of an Orally Administered Unit Dose Tablet
ZA200807348B (en) Dosage aerosols for the administration of pharmaceutical preparations
IL195822A0 (en) Segmented pharmaceutical dosage forms
HUP0700756A2 (en) Process for the preparation of pharmaceutical intermediers
GB2475701B (en) A process for the preparation of an orally administered anthelmintic unit dose tablet
GB0501536D0 (en) Product for orally administering a substance
GB2437054B (en) A process for the preparation of an orally administered unit dose tablet
SI2164468T1 (en) Method for the production of a form of administration of a medicament
AU2007905868A0 (en) Process for the preparation of a solid pharmaceutical dosage form
ZA200810270B (en) Segmented pharmaceutical dosage forms
IL193929A0 (en) A device for orally administering medicine
EP2156838A4 (en) Method for producing pharmaceutical tablet

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20150411